Eric Shen

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study

Steven D. Nathan, Aaron B. Waxman, Sudarshan Rajagopal et al. · The Lancet Respiratory Medicine · 2021 · 128 citations

Asthma, Pulmonary Arterial Hypertension, Advanced Lung Disease +10

Sudden unexpected death as a result of anomalous origin of the right coronary artery from the left sinus of Valsalva

Jeffrey M. Isner, Eric Shen, Elizabeth T. Martin et al. · The American Journal of Medicine · 1984 · 78 citations

Left Sinus, Cardiovascular Disease, Anomalous Origin +5

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial

Steven D. Nathan, Victor F. Tapson, Jean Elwing et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 66 citations · Full text

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · European Respiratory Journal · 2023 · 52 citations · Full text

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes

Steven D. Nathan, C. Q. Deng, Christopher S. King et al. · CHEST Journal · 2022 · 39 citations · Full text